Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Concurrent Technologies Corporation Announces Retirement of Vice President Tim Tibbits and Appointment of Hans DeViso as Successor

May 20, 2026

Alpha Cash Now Available on Android: Google Play Launch Puts Full Mobile Coverage in Place

May 20, 2026

NBB Expands into Auto Services M&A with Addition of Two Experienced Investment Banking Leaders

May 20, 2026

Sustainability Leader Ashley McKeon Selected as Soil Health Institute’s President and CEO

May 20, 2026

SLT CargoPay Introduces a New Web3 Infrastructure for Cargo Transportation Payments

May 20, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Envetec Receives Massachusetts Approval for GENERATIONS® Medical and Biological Waste Treatment Technology
Press Release

Envetec Receives Massachusetts Approval for GENERATIONS® Medical and Biological Waste Treatment Technology

By News RoomMay 20, 20262 Mins Read
Envetec Receives Massachusetts Approval for GENERATIONS® Medical and Biological Waste Treatment Technology
Share
Facebook Twitter LinkedIn Pinterest Email

BIRDHILL, Ireland, May 20, 2026 (GLOBE NEWSWIRE) — Envetec Sustainable Technologies Limited (Envetec), a leading sustainability innovator in clean technology for healthcare and life sciences, today announced that the Massachusetts Department of Public Health has approved its GENERATIONS® technology as an alternative treatment method for the on-site treatment of regulated medical and biological waste in the Commonwealth of Massachusetts.

“Massachusetts approval confirms that GENERATIONS meets stringent regulatory requirements for the safe and effective on-site treatment of regulated medical and biological waste,” said Malcolm Bell, CEO of Envetec. “Based on our scientific and operational data, GENERATIONS can help customers meet their sustainability goals, including CO2 reduction, landfill avoidance, and recycling of waste streams that incumbent thermal processes such as autoclaving and incineration cannot achieve.”

The patented GENERATIONS technology both shreds and disinfects regulated medical and biological waste and meets the minimum STAATT IV (6 log10) microbial inactivation standard.

Massachusetts regulates medical or biological waste under 105 CMR 480.000, including 105 CMR 480.550, which allows the Department of Public Health to approve alternative treatment. The Department’s approval of GENERATIONS provides regulatory clarity for organizations standardizing on-site treatment in Massachusetts.

With approvals in New York, Texas, and Massachusetts, Envetec is expanding the U.S. regulatory footprint for GENERATIONS, supporting healthcare systems, biopharmaceutical manufacturers, contract laboratories, and other organizations seeking standardized, sustainable treatment solutions across multiple sites and jurisdictions. Envetec also anticipates approval in additional key states, with submissions under review.

About Envetec Sustainable Technologies

Envetec Sustainable Technologies is a cleantech company pioneering safe, non-thermal, on-site treatment of regulated medical and biological waste for healthcare and life sciences organizations. Its patented GENERATIONS® process enables facilities to disinfect and shred regulated medical and biological waste at the point of generation, producing treated material suitable for resource recovery. By providing an alternative to traditional thermal treatment methods, including autoclaving and incineration, Envetec helps healthcare and life sciences organizations meet sustainability goals, reduce emissions, support resource recovery, and comply with emerging waste regulations.

Envetec Contact

Sunny Uberoi

+1 917 747 2018

[email protected]

Photos accompanying this announcement are available at:

https://www.globenewswire.com/NewsRoom/AttachmentNg/059c8d8d-8eee-48a5-a720-6c924d68e2c0

https://www.globenewswire.com/NewsRoom/AttachmentNg/41e45ded-a3aa-4482-98b7-9252ec67790d

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Concurrent Technologies Corporation Announces Retirement of Vice President Tim Tibbits and Appointment of Hans DeViso as Successor

Alpha Cash Now Available on Android: Google Play Launch Puts Full Mobile Coverage in Place

NBB Expands into Auto Services M&A with Addition of Two Experienced Investment Banking Leaders

Sustainability Leader Ashley McKeon Selected as Soil Health Institute’s President and CEO

SLT CargoPay Introduces a New Web3 Infrastructure for Cargo Transportation Payments

Regula Partners with V-Key to Strengthen Mobile Identity Security Across Asia-Pacific

Dyne Therapeutics Announces Initiation of Phase 3 FORZETTO Trial of Z-Rostudirsen in Duchenne Muscular Dystrophy (DMD) Ahead of Planned BLA Submission for U.S. Accelerated Approval

IUX Publishes Market Insight on AI Momentum and U.S. Equity Markets

Bitget lists Nexus (NEX) for Spot Trading

Editors Picks

Alpha Cash Now Available on Android: Google Play Launch Puts Full Mobile Coverage in Place

May 20, 2026

NBB Expands into Auto Services M&A with Addition of Two Experienced Investment Banking Leaders

May 20, 2026

Sustainability Leader Ashley McKeon Selected as Soil Health Institute’s President and CEO

May 20, 2026

SLT CargoPay Introduces a New Web3 Infrastructure for Cargo Transportation Payments

May 20, 2026

Latest News

Android 17 is getting its own version of Apple’s Handoff

May 20, 2026

Regula Partners with V-Key to Strengthen Mobile Identity Security Across Asia-Pacific

May 20, 2026

Dyne Therapeutics Announces Initiation of Phase 3 FORZETTO Trial of Z-Rostudirsen in Duchenne Muscular Dystrophy (DMD) Ahead of Planned BLA Submission for U.S. Accelerated Approval

May 20, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version